SCR 9140
Alternative Names: SCR-9140Latest Information Update: 27 Jun 2023
At a glance
- Originator Simcere Zaiming
- Class Antineoplastics
- Mechanism of Action SMARCA2 protein degraders
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Cancer